SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-082730
Filing Date
2024-07-10
Accepted
2024-07-10 16:41:51
Documents
12
Period of Report
2024-07-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eldn-20240710.htm   iXBRL 8-K 60930
2 EX-10.1 eldn-ex10_1.htm EX-10.1 157077
  Complete submission text file 0000950170-24-082730.txt   363905

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eldn-20240710.xsd EX-101.SCH 24851
14 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20240710_htm.xml XML 4703
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 241110364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)